JDD March Issue Highlights and Editor Picks
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au …
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au … Continue reading "JDD March Issue Highlights and Editor Picks"
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … 
This article offers pearls that are often overlooked, but can make a big impact in the quality of care we provide to our patients with psoriasis. If all four are too difficult to include in your next clinic visit, focus on just one or two that you can you incorporate into your regular care of patients with psoriasis.
1. Psoriatic Arthritis
We all know that 30% of psoriasis patients develop psori … 